Institutional Exposure To Novabay Pharmaceuticals Inc (NBY)
Novabay Pharmaceuticals Inc (NBY) concluded trading on Thursday at a closing price of $0.16, with 3.35 million shares of worth about $0.54 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -74.44% during that period and on Thursday the price saw a gain of […]
Novabay Pharmaceuticals Inc (AMEX: NBY) Loses -94.87% From High. Why That Could Change?
Currently, there are 6.53M common shares owned by the public and among those 6.37M shares have been available to trade. Insiders at the company have transacted a total of 6 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 6 of these insider trades were purchases, […]
Novabay Pharmaceuticals Inc (AMEX: NBY) Loses -93.14% From High. Why That Could Change?
Citadel Securities LLC recently announced the acquisition of new stake in Novabay Pharmaceuticals Inc (AMEX:NBY). This fresh investment now brings its stake to 1.30% valued currently at $17370.0. In addition, Renaissance Technologies LLC raised its holdings by 13900.0 to 58823.0 shares. Currently, there are 6.53M common shares owned by the public and among those 6.37M […]
Gains May Be On The Menu For Novabay Pharmaceuticals Inc (AMEX: NBY)
Citadel Securities LLC recently announced the acquisition of new stake in Novabay Pharmaceuticals Inc (AMEX:NBY). This fresh investment now brings its stake to 1.30% valued currently at $25544.0. In addition, Renaissance Technologies LLC raised its holdings by 13900.0 to 58823.0 shares. With over 19.56 million Novabay Pharmaceuticals Inc (NBY) shares trading Tuesday and a closing […]